Delivering inhaled drugs to the small airways - Does it matter?

O.S. Usmani (London, United Kingdom)

Source: International Congress 2015 – Inhaled drugs: within and beyond the lungs
Session: Inhaled drugs: within and beyond the lungs
Session type: Symposium
Number: 4942
Disease area: Airway diseases

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O.S. Usmani (London, United Kingdom). Delivering inhaled drugs to the small airways - Does it matter?. International Congress 2015 – Inhaled drugs: within and beyond the lungs

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment
Source: Eur Respir J 2008; 31: 1145-1147
Year: 2008


It does matter which inhalative corticosteroids asthmatic patient use! Looking at ICS side effects from users perspective
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008


Acute effects of bronchial thermoplasty: a matter of concern or an indicator of possible benefit to small airways?
Source: Eur Respir J , 49 (3) 1700029; DOI: 10.1183/13993003.00029-2017
Year: 2017


Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015


Is there room for further innovation in inhaled therapy for airways disease?
Source: Breathe, 14 (3) 216; 10.1183/20734735.020318
Year: 2018



Inhaled therapies: can they breathe new life into asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020


Particle size matters: diagnostics and treatment of small airways involvement in asthma
Source: Eur Respir J 2011; 37: 532-540
Year: 2011



What to use INSTEAD of inhaled corticosteroids in COPD?
Source: Eur Respir J 2014; 44: 1391-1393
Year: 2014


Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
Source: Eur Respir J 2011; 38: 1328-1335
Year: 2011



Improvement of small airway deposition of corticosteroids by smart nebulisation
Source: International Congress 2018 – Asthma and drugs
Year: 2018


Assessing regional airways responses to inhaled bronchodilators in asthmatics
Source: Annual Congress 2010 - Airways mechanics in different applications
Year: 2010

Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004

Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015

What the pulmonary specialist should know about the new inhalation therapies
Source: Eur Respir J 2011; 37: 1308-1417
Year: 2011



Knowing when to stop: inhaled corticosteroids and COPD
Source: Eur Respir J 2015; 46: 1236-1238
Year: 2015


Inhaled corticosteroids in preschool asthmatics: are they effective and who benefits most?
Source: Eur Respir J 2003; 22: Suppl. 45, 534s
Year: 2003

Monitoring asthma: no matter how?
Source: Eur Respir J 2016; 48: 614-616
Year: 2016


Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Year: 2007